The Motley Fool has positions in and recommends Abbott Laboratories. The Motley Fool ... Inc. Founded in 1993 in Alexandria, VA., by brothers David and Tom Gardner, The Motley Fool is a multimedia ...
4don MSN
The U.S. Department of Energy announced Tuesday that it is teaming up with yet another energy company as part of a mission to ...
Competing interests PPT has served as a paid consultant to Abbott Laboratories Ltd, Astellas, AstraZeneca, Bristol-Myers Squibb, Eli Lilly and Company, Funxional Therapeutics, GlaxoSmithKline, Johnson ...
Let's not forget about Abbott Laboratories' impressive streak of 52 consecutive annual dividend increases, which also makes ...
Piper Sandler initiates coverage on Abbott with an Overweight rating, citing its diversified business model, strong medtech ...
Over the past few years, Abbott Laboratories' (NYSE: ABT) business has been a bit of a roller coaster. The pandemic disrupted its medical device business, but it was later able to smooth out those ...
The stock's fall snapped a two-day winning streak.
3d
Adam Maeder, an analyst from Piper Sandler, has initiated a new Buy rating on Abbott Laboratories (ABT). Adam Maeder has given his Buy rating ...
In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Buy rating on Abbott Laboratories (ABT – Research Report), ...
Abbott Laboratories closed $4.01 short of its 52-week high ($121.64), which the company reached on March 8th.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback